Celebrating a decade of impact: SciLifeLab’s Clinical Genomics platform turns 10

SciLifeLab’s Clinical Genomics platform is marking its 10-year anniversary, celebrating a decade of innovation, collaboration, and impact on research and healthcare. With nodes established at all seven of Sweden’s medical faculties, the platform today plays an important role in providing expertise and service to clinical researchers in genomics-based assays. In addition, Clinical genomics initiated Genomic Medicine Sweden (GMS),was vital in the pandemic response efforts and has today evolved into the cornerstone of precision diagnostics in Sweden.

Reflecting on the journey, outgoing director Thoas Fioretos highlights the platform’s contributions to advancing whole-genome sequencing for rare diseases, cancer diagnostics, and the adoption of standardized data analysis pipelines across Sweden. Today, Clinical Genomics is the largest SciLifeLab platform, with a proven track record of bringing cutting-edge research into clinical practice.

”I am truly impressed by the enormous progress we have made thanks to all the experts working within our platform”, says Thoas Fioretos

As the incoming director Colum Walsh takes the lead, the focus shifts to the future of clinical genomics and evaluation of new technologies in the field. 

“It will be important to remain engaged with our current partners, as well as to foster relations with the new centers for precision medicine and other initiatives in the life science community. Ongoing work in our Technology Focus Areas aims to determine the feasibility and most appropriate application of new technologies and  is as important now as ever, with new approaches such as long-read sequencing, ultrasensitive detection, and AI-driven diagnostics all under current evaluation” says Colum Walsh.

Looking ahead, the platform will expand collaborations across SciLifeLab, moving beyond diagnostics toward better targeting and evaluation of treatment modalities. On a European scale, Walsh stresses the importance of international alignment

“Through partnerships with our European colleagues, we must ensure that we align with transnational initiatives that benefit both patients and public health in general, such as the European Health Data Space”, says Colum Walsh.

Join the celebration! Register now for the 10-year anniversary symposium on April 10-11 in Gothenburg, where experts will discuss the past, present, and future of genomic technologies in precision diagnostics.

Register here: Clinical Genomics 10th Anniversary sc